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LIVER RESECTION FOR METASTATIC COLON CARCINOMA
Registry ofHepatic Metasases (Kevin S. Hughes, et al) (1988)
Resection ofthe liverfor colorectal carcinoma metastases: a multi-institutional
study of indications for resection. Surgery, 103, 278-288.
ABSTRACT
In an investigation of the indications for hepatic resection in the treatment of
colorectal carcinoma metastases, the records of 859 patients who had undergone this
procedure were reviewed. This patient group, from 24 institutions, was found to have
a 5-year actuarial survival of33% and a 5-year actuarial disease-free survival of21%.
The only factors that might by themselves be considered contraindications to hepatic
resection are the presence of positive hepatic nodes, the presence of resectable extra-
hepatic metastases, or the presence offour or more metastases. Other factors that had
a negative effect on long-term survival were margins of resection on the liver
metastases less than or equal to 1 cm (S [5-year actuarial survival] 23%), the
presence of positive mesenteric nodes in the primary tumor specimen (S 23%), and
a disease-free interval of less than 1 year (S 24%). The effect of any one of these
factors was not great enough to contraindicate resection. However, combinations of
prognostic factors must be considered before resection is recommended. The overall
5-year survival rate for this large series has been very satisfying. Decision making in
the future must take into account such factors as numbers of metastases, extrahepatic
involvement, and stage of the primary tumor.
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I applaud the HPB world. It is not often that 24 leading centers from around the
world cooperate by amalgamating their data to obtain a better understanding of a
difficult medical problem. This group collected and studied 859 patients who had
undergone curative hepatic resection for colorectal carcinoma metastases. Unfortu-
nately their analysis extends back as far as 1948. As the field has developed so
rapidly in the past 20 years it would have been better to restrict their material and
concentrate on patients treated after 1965. Had they involved even more centers
it may have been possible to study the data for each decade separately. As many
as 64% of their patients had one single tumour resected. Their finding of a 5-year
actuarial survival of 33% and a 5-year actuarial disease-free survival of 21% is
similar to that reported previously by individual centers, including our own. The
present study supports the conclusions from previous investigations which h.ighligh-
ted the negative influence on survival when there were positive hepatic nodes at
the time of operation, when resectable extrahepatic metastases were present and
when there were four or more metastic deposits in the liver. It also confirmed the
negative effect on long-term survival when the resection margin was less than or
equal to 1 cm (5-year survival 23%), the presence of positive mesenteric nodes in
the original specimen for the resection of the primary tumour (5-year survival 23%)
and when a disease-free interval of less than one year existed between the resection
of the primary colorectal tumour and the hepatic resection for metastases (5-year
survival 24%).
The analysis of the large number of patients with solitary metastases (509 pa-
tients) is of special interest. The 5-year survival was 37% in this group and the
disease-free survival 25%. Note also that patients with tumours less than 4 cm
fared as well with a wedge resection as when a formal anatomical liver resection
was performed. However, patients with solitary metastases larger than 4 cm fared
better with an anatomical liver resection. Note that their patients having anatom-
ical resections included less Duke’s C patients (51%) and less synchronous metas-
tases (37%) than those patients who underwent a wedge resection (67% Duke’s C
and 57% synchronous). In my opinion it is important that attempts be made in the
future to further analyse this specific group of tumours. When the present material
is compared with the Lund series from 19861 it is interesting that both series have
36% multiple tumours. However, solitary lesions were 64% in the present study
and only 49% in the Lund material. Our study contained a third group with solitary
tumours with multiple small satellite tumours in the surrounding liver. The present
study does not indicate where these cases are included in their data. Our study
showed that these patients accounted for as many as 15% of the patients and had
a great influence on survival with a 0% 3 and 5-year survival. In future studies this
subset should be identified and reported separately.
It has been calculated that only some 10% of patients who are suitable for
hepatic resection for colorectal metastases are referred to a surgical institution
capable of undertaking the procedure because of prejudices based on three
common misconceptions. These are: that hepatic metastases are fatal regardless of
treatment; heptatic resection is only effective for solitary metastases; hepatic resec-
tions are accompanied by a high morbidity and a high mortality. None of these
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misconceptions are true today. The results of the study being reviewed emphasises
the importance of such patients being referred to major centers.
In my opinion the morbidity rates can be improved significantly even though
most of the complications were minor. Operative mortality should be below 5%
in expert hands. When one notes that 30% of the patients with solitary tumours
and as many as 18% of the patients with multiple tumours survived 5 years this
provides convincing evidence favouring liver resection. Note that the resection of
colorectal metastases in the liver is probably more justified than surgery for many
other types of malignant lesions including primary surgery for gastric or pancreatic
carcinoma. I hope that an awareness of these results will change the referral pattern
in many areas of the world.
S. Bengmark
Dept of Surgery
Lund University
221 85, Lund, Sweden
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STENTING IN OBSTRUCTIVE JAUNDICE:
ERCP VS PTC--NO FINAL ANSWER
A.G. Speer, P.B. Cotton, R.C.G. Russel, R.R. Mason, A.R.W. Hatfield,
J.W.C. Leung, K.D. Macrae, J. Houghton, C.A. Lennon. (1987)
Randomised trial of endoscopic versus percutaneous stent insertion in
malignant obstructive jaundice. Lancet ii, 57-62.
ABSTRACT
Patients with biliary obstruction due to malignant disease, and judged unfit for open
operation, were randomised to have a biliary stent inserted either endoscopically
via the papilla of Vater or percutaneously. Analysis after 75 patients had been
entered showed that the endoscopic method had a significantly higher success rate
for relief of jaundice (81% versus 61%, p 0.017) and a significantly lower 30-day
mortality (15% versus 33%, p 0.016). The higher mortality after percutaneous
stents was due to complications associated with liver puncture (haemorrhage and
bile leaks). When stenting is indicated in elderly and frail patients the endoscopic
method should be tried first.
Submit your manuscripts at
http://www.hindawi.com
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2013
The Scientific 
World Journal
International Journal of
Endocrinology
Hindawi Publishing Corporation
http://www.hindawi.com
Volume 2013
ISRN 
Anesthesiology
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
PPAR
Resea rch
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
ISRN 
Allergy
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
BioMed Research 
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
ISRN 
Addiction
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
 Computational and  
Mathematical Methods 
in Medicine
ISRN 
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Clinical &
Developmental
Immunology
Hindawi Publishing Corporation
http://www.hindawi.com
Volume 2013
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2013
Hindawi Publishing Corporation
http://www.hindawi.com
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
ISRN 
Biomarkers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
MEDIATORS
INFLAMMATION
of
